Need extra support quickly? We are working with clients around the world right now to help them tackle new challenges from COVID-19.  

How can we help you? Learn More >

Patrick Donnelly

Board Member

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

April 1, 2020
COVID-19 Pandemic in the EU: Fraudulent Medicines, Test Kit Shortage,…
The COVID-19 pandemic is creating many new challenges for our industry around the world.… Read More
March 31, 2020
Ten Tips for Conducting Successful Virtual FDA Meetings in the…
Ten tips for Sponsors now facing virtual FDA meetings rather than face-to-face interactions, and how to… Read More
March 25, 2020
Health Authorities’ Information on the COVID-19 Pandemic Throughout Europe, Part…
How is COVID-19 affecting clinical trials across Europe? Hanneke Dominicus provides more information on… Read More
More Articles

UPCOMING Events

All Events
Contact Us